Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
24.50
+0.08 (0.33%)
At close: Sep 4, 2026, 4:00 PM EDT
24.20
-0.30 (-1.22%)
After-hours: Sep 4, 2026, 7:55 PM EDT
Elanco Animal Health Revenue
Elanco Animal Health had revenue of $1.37B in the quarter ending June 30, 2026, with 10.23% growth. This brings the company's revenue in the last twelve months to $5.02B, up 11.95% year-over-year. In the year 2025, Elanco Animal Health had annual revenue of $4.72B with 6.22% growth.
Revenue (ttm)
$5.02B
Revenue Growth
+11.95%
P/S Ratio
2.44
Revenue / Employee
$507,071
Employees
9,900
Market Cap
12.24B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.72B | 276.00M | 6.22% |
| Dec 31, 2024 | 4.44B | 22.00M | 0.50% |
| Dec 31, 2023 | 4.42B | 6.00M | 0.14% |
| Dec 31, 2022 | 4.41B | -353.00M | -7.41% |
| Dec 31, 2021 | 4.76B | 1.49B | 45.64% |
| Dec 31, 2020 | 3.27B | 200.00M | 6.51% |
| Dec 31, 2019 | 3.07B | 4.20M | 0.14% |
| Dec 31, 2018 | 3.07B | 177.80M | 6.15% |
| Dec 31, 2017 | 2.89B | -24.50M | -0.84% |
| Dec 31, 2016 | 2.91B | 4.40M | 0.15% |
| Dec 31, 2015 | 2.91B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Viatris | 14.74B |
| Zoetis | 9.53B |
| Dr. Reddy's Laboratories | 3.50B |
| Neurocrine Biosciences | 3.37B |
| United Therapeutics | 3.15B |
| Amneal Pharmaceuticals | 3.12B |
| Hims & Hers Health | 2.58B |
| Alkermes | 1.67B |
ELAN News
- 9 days ago - Elanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing Facility - PRNewsWire
- 4 weeks ago - Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species - PRNewsWire
- 4 weeks ago - Elanco Animal Health Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - Elanco Animal Health Earnings release: Q2 2026 - Filings
- 4 weeks ago - Elanco Animal Health Slides: Q2 2026 - Filings
- 4 weeks ago - Elanco Animal Health Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Elanco Animal Health Reports Second Quarter 2026 Results - PRNewsWire
- 5 weeks ago - Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society's Growing Needs - PRNewsWire